TickerFacts.

Nu-Med Plus, Inc. (NUMD): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$179.9K
Year ended 2022-12-31
2012-12-31: -$256.4K2013-12-31: -$230.4K2014-12-31: -$1.14M2015-12-31: -$939.3K2016-12-31: -$1.22M2017-12-31: -$454.0K2018-12-31: -$1.15M2019-12-31: -$1.01M2020-12-31: -$1.98M2021-12-31: -$830.1K2022-12-31: -$179.9K-$179.9K
2012-12-31 EBITDA (USD) 2022-12-31
Period endedEBITDAChange YoYSource filing
2022-12-31-$179.9Kn/m2024-03-26, From 2022-01-01
2021-12-31-$830.1Kn/m2023-04-03, From 2021-01-01
2020-12-31-$1.98Mn/m2022-04-11, From 2020-01-01
2019-12-31-$1.01Mn/m2021-03-31, From 2019-01-01
2018-12-31-$1.15Mn/m2020-03-30, From 2018-01-01
2017-12-31-$454.0Kn/m2019-04-01, From 2017-01-01
2016-12-31-$1.22Mn/m2018-04-03, From 2016-01-01
2015-12-31-$939.3Kn/m2017-04-19, From 2015-01-01
2014-12-31-$1.14Mn/m2016-04-13, From 2014-01-01
2013-12-31-$230.4Kn/m2015-03-23, From 2013-01-01
2012-12-31-$256.4Kn/a2014-02-21, From 2012-01-01